Tower Research Capital (TRC)’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.67K | Buy |
+3,356
| New | +$4.67K | ﹤0.01% | 4286 |
|
|
2025
Q1 | – | Sell |
-34,423
| Closed | -$45.1K | – | 5690 |
|
|
2024
Q4 | $45.1K | Buy |
34,423
+23,127
| +205% | +$30.3K | ﹤0.01% | 2623 |
|
|
2024
Q3 | $38.9K | Buy |
11,296
+10,777
| +2,076% | +$37.1K | ﹤0.01% | 2866 |
|
|
2024
Q2 | $1.71K | Sell |
519
-3,457
| -87% | -$11.4K | ﹤0.01% | 5104 |
|
|
2024
Q1 | $18.7K | Buy |
3,976
+3,776
| +1,888% | +$17.8K | ﹤0.01% | 3058 |
|
|
2023
Q4 | $1.46K | Sell |
200
-5,926
| -97% | -$43.3K | ﹤0.01% | 5377 |
|
|
2023
Q3 | $74K | Buy |
6,126
+3,899
| +175% | +$47.1K | ﹤0.01% | 2221 |
|
|
2023
Q2 | $23.6K | Sell |
2,227
-9,089
| -80% | -$96.2K | ﹤0.01% | 3214 |
|
|
2023
Q1 | $111K | Buy |
11,316
+9,529
| +533% | +$93.5K | ﹤0.01% | 1775 |
|
|
2022
Q4 | $26K | Sell |
1,787
-7,548
| -81% | -$110K | ﹤0.01% | 2887 |
|
|
2022
Q3 | $113K | Buy |
+9,335
| New | +$113K | ﹤0.01% | 2463 |
|
|
2022
Q2 | – | Sell |
-4,909
| Closed | -$70K | – | 6455 |
|
|
2022
Q1 | $70K | Buy |
4,909
+4,898
| +44,527% | +$69.8K | ﹤0.01% | 2460 |
|
|
2021
Q4 | $0 | Sell |
11
-185
| -94% | – | ﹤0.01% | 6509 |
|
|
2021
Q3 | $5K | Sell |
196
-3,340
| -94% | -$85.2K | ﹤0.01% | 4879 |
|
|
2021
Q2 | $110K | Buy |
3,536
+311
| +10% | +$9.68K | ﹤0.01% | 2355 |
|
|
2021
Q1 | $98K | Buy |
3,225
+1,419
| +79% | +$43.1K | ﹤0.01% | 2601 |
|
|
2020
Q4 | $62K | Buy |
1,806
+1,804
| +90,200% | +$61.9K | ﹤0.01% | 2880 |
|
|
2020
Q3 | $0 | Sell |
2
-871
| -100% | – | ﹤0.01% | 5057 |
|
|
2020
Q2 | $27K | Buy |
+873
| New | +$27K | ﹤0.01% | 3516 |
|